Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 65Myelodysplastic Syndromes 64Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 40Multiple Myeloma 35Hodgkin Disease 35Lymphoma, Non-Hodgkin 34Leukemia, Myeloid, Chronic-Phase 34Myeloproliferative Disorders 33Leukemia, Myeloid, Accelerated Phase 31Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Congenital Abnormalities 28Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Neoplasms, Plasma Cell 23Lymphoma, Large-Cell, Immunoblastic 23Anemia, Refractory, with Excess of Blasts 23Blast Crisis 22Myelodysplastic-Myeloproliferative Diseases 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Graft vs Host Disease 19Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 17Waldenstrom Macroglobulinemia 14Recurrence 14

Interventions

fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Thiotepa 2Melphalan 2Cyclosporins 2Cyclosporine 2Antilymphocyte Serum 2Alemtuzumab 2plerixafor 1Voriconazole 1Tacrolimus 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Clofarabine 1Busulfan 1Blood Specimen Collection 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Immunologic Deficiency Syndromes × Antilymphocyte Serum × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡